93 completed, 21 terminated, 14 unknown, 4 recruiting. 46 Phase 4, 36 Phase 3, 26 Not applicable, 17 Phase 2, 7 Phase 1.
Follow Haloperidol: new trials by email Literature Review of Haloperidol trials Research Report on Haloperidol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Haloperidol For Outpatient Symptom Management in Patients Diagnosed With Cannabinoid Hyperemesis Syndrome in the Emergrency Department Haloperidol - Cannabinoid Hyperemesis Syndrome | Early Phase 1 | Not yet recruiting | University of Illinois at Chicago | 100 | 2026-11-01 | 2026-09-01 |
| Do Antipsychotics Block Insulin Action in the Brain: is it a Class Effect? Haloperidol, Placebo, Insulin Lispro - Brain Insulin Sensitivity, Healthy Controls | Phase 4 | Recruiting | Centre for Addiction and Mental Health | 35 | 2025-12-11 | 2026-04-02 |
| Comparing Haloperidol to Olanzapine in the Treatment of Suspected Cannabinoid Hyperemesis in the Emergency Department Olanzapine 10 milligram, Haloperidol - Cannabinoid Hyperemesis Syndrome | Phase 3 | Completed | Mercy Bon Secours Saint Vincent Medical Center | 31 | 2025-11-06 | 2026-10-14 |
| Quality of Life, Safety and Compliance of Patients Using Monotherapy or Combinatorial Therapy With Quetiapine for Treatment of Schizophrenia or Bipolar Affective Disorder Quetiapine (drug), quetiapine + aripiprazole, quetiapine + haloperidol - Schizophrenia, Bipolar Affective Disorder | Recruiting | Bosnalijek D.D | 500 | 2025-10-30 | 2026-10-15 | |
| Comparison of Haloperidol and Dexmedetomidine for Delirium and Agitation in ICU Patients With Traumatic Brain Injury Haloperidol, Dexmedetomidine - Traumatic Brain Injury, Delirium | Not applicable | Not yet recruiting | Benha University | 40 | 2025-06-15 | 2025-05-28 |
| Comparison of Haloperidol and Ondansetron in Reducing Postoperative Nausea and Vomiting in RA-SAB Patients Haloperidol, Ondansetron 4mg - Postoperative Nausea and Vomiting (PONV), Subarachnoid Block | Not applicable | Completed | Rully Riyandika | 40 | 2025-01-15 | 2025-07-28 |
| The Effectiveness of HP and TMZ Synergism on Adult Recurrence GBM Haloperidol Tablets, Temozolomide - Glioblastoma Multiforme | Phase 2 | Not yet recruiting | Southern Medical University, China | 200 | 2024-12-01 | 2024-01-23 |
| Haloperidol for Pain Control in Patients With Acute Musculoskeletal Back Pain in the Emergency Department Haloperidol, Ketorolac Tromethamine - Back Pain, Chronic Pain | Phase 4 | Recruiting | Western Michigan University School of Medicine | 75 | 2024-07-09 | 2024-07-10 |
| Intranasal Dexmedetomidine vs. Standard of Care for Emergency Department (ED) Procedural Sedation in the Older Adult Dexmedetomidine, Lorazepam, Haloperidol - Altered Mental Status | Phase 3 | Unknown | State University of New York - Upstate Medical University | 60 | 2024-06-01 | 2024-04-22 |
| Comparative Efficacy of Dexamethasone - Ondansetron Versus Dexamethasone - Haloperidol in Reducing PONV Ondansetron, Haloperidol - Laparoscopic Cholecystectomy | Phase 2 | Completed | Universitas Padjadjaran | 38 | 2023-11-01 | 2024-05-24 |
| Quetiapine Versus Haloperidol in the Management of Hyperactive Delirium Quatiapine, Haloperidol - Hyperactive Delirium | Phase 3 | Completed | Alexandria University | 100 | 2023-04-09 | 2023-08-30 |
| A Study of Olanzapine in Patients With Acute Agitation Olanzapine, Haloperidol - Acute Agitation | Phase 3 | Unknown | Qilu Pharmaceutical Co., Ltd. | 318 | 2023-03-28 | 2023-04-07 |
| Combination of Haloperidol and Magnesium for Delirium Prevention in Critically Ill Elderly Haloperidol Injection - Delirium in Old Age | Phase 2 / Phase 3 | Completed | Ain Shams University | 135 | 2022-11-01 | 2023-12-13 |
| Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy Haloperidol, Chlorpromazine, Valproate - Delirium, Epileptics | Phase 2 / Phase 3 | Recruiting | M.D. Anderson Cancer Center | 42 | 2022-07-19 | 2025-11-18 |
| HALO Trial: Haloperidol vs Olanzapine in Hyperactive Delirium in Palliative Care Patients; A Multi-Centre, Randomised-Controlled Trial Haldol 2mg/ml oral solution, Olanzapine Actavis 5mg orodispersible tablet - Haloperidol, Advanced Cancer | Phase 3 | Completed | Tan Tock Seng Hospital | 22 | 2022-05-18 | 2026-10-05 |
| Haloperidol, Droperidol, Ondansetron in Cannabis Hyperemesis Droperidol, Haloperidol, Ondansetron 8mg - Cyclic Vomiting Syndrome | Phase 3 | Terminated | Corewell Health South | 32 | 2021-08-30 | 2025-05-21 |
| Meth-OD: A Study of IXT-m200 in Patients With Toxicity From Methamphetamine Overdose IXT-m200, Lorazepam, Haloperidol - Methamphetamine Intoxication (Disorder) | Phase 2 | Terminated | InterveXion Therapeutics, LLC | 20 | 2021-06-30 | 2023-11-18 |
| Haloperidol for the Treatment of Nausea and Vomiting in the ED Haloperidol, Ondansetron - Vomiting, Nausea | Phase 4 | Completed | Western Michigan University School of Medicine | 60 | 2021-04-01 | 2023-06-01 |
| Learning and Decision-making placebo, haloperidol 2mg, propranolol 40mg - Motivation | Not applicable | Completed | Maastricht University | 150 | 2021-03-01 | 2023-08-28 |
| Study to Compare Clozapine vs Treatment as Usual in People With Intellectual Disability & Treatment-resistant Psychosis Clozapine, haloperidol, pimozide, olanzapine, risperidone, amisulpride - Psychosis, Intellectual Disability | Phase 2 | Unknown | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 75 | 2020-11-26 | 2024-03-20 |
Showing 20 of 141. Sign in to see all of them.
Schizophrenia (40) · Delirium (25) · Psychomotor Agitation (17) · Psychotic Disorders (14) · Bipolar Disorder (7) · Nausea (6) · Aggression (5) · Migraine Disorders (4) · Vomiting (4) · Anxiety Disorders (3) · Cannabinoid Hyperemesis Syndrome (3) · Cognitive Dysfunction (3) · Confusion (3) · Critical Illness (3) · Emergencies (3)
Eli Lilly and Company (4) · Centre for Addiction and Mental Health (3) · M.D. Anderson Cancer Center (3) · Western Michigan University School of Medicine (3) · Amsterdam UMC, location VUmc (2) · Hennepin Healthcare Research Institute (2) · Indiana University (2) · Janssen Scientific Affairs, LLC (2) · KU Leuven (2) · Leiden University Medical Center (2) · New York State Psychiatric Institute (2) · Organon and Co (2) · The University of Hong Kong (2) · US Department of Veterans Affairs (2) · University Hospitals Cleveland Medical Center (2)
United States (45) · Canada (12) · Netherlands (10) · China (6) · Germany (5) · Spain (5) · Brazil (3) · Egypt (3) · India (3) · Indonesia (3) · Mexico (3) · Taiwan (3) · United Kingdom (3) · Belgium (2) · Croatia (2)
Martha Sajatovic, MD (3) · David Hui (2) · Eline Vandael, PhD-student (2) · Jessica McCoy, MD (2) · Adel Elsheshai, MD (1) · Alan I Green, MD (1) · Alberto Parabiaghi, M.D. (1) · Aldy Heriwardito, Doctor (1) · Alexa Hollinger, MD (1) · Amalia Lafuente Flo, Pharmacology professor (1) · Anders Perner, MD,PhD (1)
PMID 38958149, PMID 39831535, PMID 11087767, PMID 11495717, PMID 11559786, PMID 12505794, PMID 12629531, PMID 14645311, PMID 14735295, PMID 16185814, PMID 16754835, PMID 16929307, PMID 17015817, PMID 17306626, PMID 17335321, PMID 17851042, PMID 18041437, PMID 18052570, PMID 18052574, PMID 18794642, PMID 18840034, PMID 19093703, PMID 19228178, PMID 19454032, PMID 1950621, PMID 20057930, PMID 20095068, PMID 20226624, PMID 20520283, PMID 20528148, PMID 21119516, PMID 21328719, PMID 21554991, PMID 21645330, PMID 21710401, PMID 21845596, PMID 21868369, PMID 21975110, PMID 22122006, PMID 22134043, PMID 22144928, PMID 22152404, PMID 22194182, PMID 22950484, PMID 23422376, PMID 23609398, PMID 23926422, PMID 24261644, PMID 24434094, PMID 24519692
2009 (4), 2017 (1), K23HL078760 (1), R01AG034205 (1), R01MH052376 (1), R01MH055735 (1), R01MH081107 (1), R15AG034915 (1), R21MH114700 (1), R21NR016736 (1), U01AG010483 (1), U01DA053043 (1)